Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Nova Mentis Life Science Corp
C.NOVA
Alternate Symbol(s):
NMLSF
Healthcare
Biotechnology
Nova Mentis Life Science Corp. is a Canadian biotechnology company. The Company is engaged in developing diagnostics and psilocybin-based therapeutics for neuroinflammatory disorders. The Company has orphan drug designation in both the United States and European Union for the use of psilocybin in the treatment of fragile X syndrome (FXS). Its focus is to diagnose and treat debilitating chronic...
conditions that have unmet medical needs, such as autism spectrum disorder (ASD) and FXS. Its core scientific focus is on chronic neuroinflammatory conditions, which fall under three categories: neurodevelopmental, neurometabolic, and neurodegenerative. The Company operates in one segment, being research and development of psilocybin, and in one geographic area, being Canada, through its wholly owned subsidiaries, Nova Mentis Biotech Corp., and SwabAi Diagnostics Inc.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (CSE:NOVA)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
Next
(1931)
•••
Betteryear2
X
View Profile
View Bullboard History
Post by
Betteryear2
on Feb 16, 2022 8:15pm
Study Confirms Oral Microdose Psilocybin Treatment of Autism
VANCOUVER, BC, Feb. 16, 2022 /PRNewswire/ - Nova Mentis Life Science Corp. (CSE: NOVA) (FSE: HN3Q) (OTCQB: NMLSF) ("NOVA" or the "Company"), a
...more
(13)
•••
TheTexan
X
View Profile
View Bullboard History
Comment by
TheTexan
on Dec 03, 2021 10:51am
RE:Lets play with them ;)
Looks like you will get your .01 cent wish. Happy Holudays.
(0)
•••
Glenstock2016
X
View Profile
View Bullboard History
Post by
Glenstock2016
on Nov 11, 2021 7:41am
Lets play with them ;)
Im still buying more;) Even if it goes to 0.01 I will still buy! One day they will have to make it go back up if they want people to get in! lol
(313)
•••
mavericks2020
X
View Profile
View Bullboard History
Post by
mavericks2020
on Nov 05, 2021 5:56am
news
Nova Mentis to Present at the Wonderland: Miami Psychedelic Conference VANCOUVER, BC, Nov. 4, 2021 /CNW/ - Nova Mentis Life Science Corp. (CSE: NOVA) (FSE: HN3Q) (OTCQB: NMLSF) ("NOVA" or
...more
(126)
•••
13X2413
X
View Profile
View Bullboard History
Comment by
13X2413
on Nov 02, 2021 1:42pm
RE:A lot of very serious buyers and NOVA will be at 0.24 ¢ soon
I usually run away when the pump starts...I may stick with this for a bit longer, against my better judgement.
(471)
•••
Traderstock101
X
View Profile
View Bullboard History
Post by
Traderstock101
on Nov 02, 2021 1:14pm
A lot of very serious buyers and NOVA will be at 0.24 ¢ soon
09:33:29 H 0.155 0.045 2,000 80 National Bank 1 Anonymous K 09:33:06 H 0.155 0.045 6,000
...more
(471)
•••
Traderstock101
X
View Profile
View Bullboard History
Post by
Traderstock101
on Nov 02, 2021 1:10pm
Nova Mentis receives FDA OK for orphan drug application $$$$
2021-11-02 09:04 ET - News Release Mr. Will Rascan reports U.S. FDA APPROVES NOVA MENTIS ORPHAN DRUG APPLICATION The U.S. Food and Drug Administration has approved Nova Mentis Life
...more
(471)
•••
Traderstock101
X
View Profile
View Bullboard History
Post by
Traderstock101
on Nov 02, 2021 1:09pm
Nova's psilocybin drug receives orphan drug designation $$$$
NOVA MENTIS EARNS PSILOCYBIN ORPHAN DRUG DESIGNATION IN EUROPE FOR FRAGILE X SYNDROME Nova Mentis Life Science Corp. has received orphan drug designation from the European Medicines Agency (EMA) for
...more
(313)
•••
mavericks2020
X
View Profile
View Bullboard History
Comment by
mavericks2020
on Nov 02, 2021 9:40am
RE:big news FDA
surely accepted by health canada this month
(313)
•••
mavericks2020
X
View Profile
View Bullboard History
Post by
mavericks2020
on Nov 02, 2021 9:36am
VOLUME 900 000 IN 20 MIN.
eom
(313)
•••
mavericks2020
X
View Profile
View Bullboard History
Post by
mavericks2020
on Nov 02, 2021 9:28am
big news FDA
Nova Mentis receives FDA OK for orphan drug application 2021-11-02 09:04 ET - News Release Mr. Will Rascan reports
...more
(1931)
•••
Betteryear2
X
View Profile
View Bullboard History
Post by
Betteryear2
on Oct 26, 2021 8:09am
Earns Psilocybin Orphan Drug Designation in Europe
VANCOUVER, BC, Oct. 26, 2021 /PRNewswire/ - Nova Mentis Life Science Corp. (CSE: NOVA) (FSE: HN3Q) (OTCQB: NMLSF) ("NOVA" or the "Company"), a
...more
(13)
•••
TheTexan
X
View Profile
View Bullboard History
Post by
TheTexan
on Oct 09, 2021 3:27pm
JJ Wolf Dung. Your House of Cards
Is collapsing. So, are you hustling at The Harness Track or laying low at The Finca this weekend? Your people are telling on you. I'm loving it. Tex
(57)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Jun 03, 2021 11:57am
NOVA ...... my 1st look in a long time
What a pile o craaap! When the Reverse Split???
(13)
•••
TheTexan
X
View Profile
View Bullboard History
Post by
TheTexan
on May 06, 2021 8:51pm
Derek Lloyd ( JJ Wolf ) Ivany
SEC Enforcement file 3-16317. Affidavit of Rebecca Israel, AUSA, Boston Regional Office. (BRO) Anyone with information on activities, or whereabouts of Derek Lloyd Ivany, aka Derek Lloyd Harry Ivany
...more
Prev
1
2
3
4
5
6
7
8
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
GameSquare Announces Formation of FaZe Media, Backed by $11M Investment
Xcyte Digital Corp. Releases "Xperience" Subscription Service
Drilling Approval Received for New Mexico Lithium Project